Uh-oh! This study is no longer available.
We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.
Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
Medical Condition
Non-Alcoholic Fatty Liver Disease
Facility/Clinic
PMG Research of Winston Salem
Age
18 and older
Gender
Male/Female
Description
A research study is being conducted to evaluate the safety and efficacy of an investigational combination of medication for Nonalcoholic Steatohepatitis (NASH) and liver fibrosis.
This research study may be an option if you:
• Are suspected to have NASH with fibrosis (potential risk factors include obesity, high blood pressure, high cholesterol or Type 2 Diabetes)
• Are willing to undergo liver biopsies
• Have no other forms of chronic liver disease
Those with diabetes should have an HbA1c below 9%. Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you. Study participation is completely voluntary.
Qualified participants will receive all study-related care and study medication at no cost.
Enrollment
Open
Patient Commitment Duration
Approximately 1 year
Patient Compensation
| Financial compensation may be provided for time and travel expenses. |
Number of visits in study
Approximately 13 clinic visits
5 1151 1
